Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA Trial

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 50, Issue 5, 2011, Pages 490-498

  Woldu, Hiwot ^a   Porta, Giovanna ^b   Goldstein, Tina ^b   Sakolsky, Dara ^b   Perel, James ^b   Emslie, Graham ^c   Mayes, Taryn ^c   Clarke, Greg ^d   Ryan, Neal D ^b   Birmaher, Boris ^b   Wagner, Karen Dineen ^e   Asarnow, Joan Rosenbaum ^f   Keller, Martin B ^g   Brent, David ^b,h  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g BROWN UNIVERSITY   (United States)

^h UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

antidepressants; depression; medication adherence

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ARTICLE; CLINICIAN PILL COUNT; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PILL; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUICIDE; TREATMENT DURATION; TREATMENT NONADHERENCE; TREATMENT OUTCOME; TREATMENT REFUSAL; TREATMENT RESPONSE;

ADOLESCENT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DRUG MONITORING; DRUG RESISTANCE; DRUG SUBSTITUTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; SEROTONIN UPTAKE INHIBITORS; SUICIDE, ATTEMPTED;

EID: 79955435624     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1016/j.jaac.2011.01.018     Document Type: Article

References (49)

1. B. Birmaher, D. Brent Work Group on Quality Issues Practice parameters for the assessment and treatment of children and adolescents with depressive disorders J Am Acad Child Adolesc Psychiatry 46 2007 1503 1526
2. T.A. Hammad, T. Laughren, and J. Racoosin Suicidality in pediatric patients treated with antidepressant drugs Arch Gen Psychiatry 63 2006 332 339 (Pubitemid 43345358)
3. J. Bridge, S. Iyengar, and C.B. Salary Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials JAMA 297 2007 1683 1696
4. J.C. Fortney, J.M. Pyne, M.J. Edlund, and D. Mittal Relationship between antidepressant medication possession and treatment response Gen Hosp Psychiatry 32 2010 377 379
5. A.C. Vergouwen, A. Bakker, W.J. Katon, T.J. Verheij, and F. Koerselman Improving adherence to antidepressants: a systematic review of interventions J Clin Psychiatry 64 2003 1415 1420 (Pubitemid 41270098)
6. B. Vitiello, R.I. Shader, and C.B. Parker Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial J Clin Psychopharmacol 25 2005 243 249 (Pubitemid 40685788)
7. M.H. Trivedi, A.J. Rush, and B.N. Gaynes Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR( (*))D measurement-based care Neuropsychopharmacology 32 2007 2479 2489 (Pubitemid 350126843)
8. R.L. Robinson, S.R. Long, and S. Chang Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims J Manag Care Pharm 12 2006 43 54 (Pubitemid 47407591)
9. M.H. Trivedi, E.H. Lin, and W.J. Katon Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression CNS Spectr 12 2007 1 27
10. P. Nakonezny, C. Hughes, and T. Mayes A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder: a 12-week open trial of fluoxetine J Child Adolesc Psychopharmacol 20 2010 431 439
11. D. Drotar, R.N. Greenley, and C.A. Demeter Adherence to pharmacological treatment for juvenile bipolar disorder J Am Acad Child Adolesc Psychiatry 46 2007 831 839 (Pubitemid 46975919)
12. D. Sakolsky, J. Perel, and G. Emslie Antidepressant exposure as a predictor of clinical outcomes in the Treatment Resistant Depression in Adolescents (TORDIA) Study J Clin Psychopharmacol 31 2011 92 97
13. E.G. Smith Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: confirmatory analysis and research implications J Affect Disord 114 2009 143 148
14. R.L. Findling, N.K. McNamara, and R.J. Stansbrey The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depression J Child Adolesc Psychopharmacol 16 2006 131 145
15. N.M. Rickles, and B.L. Svarstad Relationships between multiple self-reported nonadherence measures and pharmacy records Res Social Adm Pharm 3 2007 363 377
16. M.C. Garber, D.P. Nau, S.R. Erickson, J.E. Aikens, and J.B. Lawrence The concordance of self-report with other measures of medication adherence: a summary of the literature Med Care 42 2004 649 652
17. R.E. Grymonpre, C.D. Didur, P.R. Montgomery, and D.S. Sitar Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly Ann Pharmacother 32 1998 749 754 (Pubitemid 28341105)
18. M.J. Byerly, A. Thompson, and T. Carmody Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia Psychiatr Serv 58 2007 844 847 (Pubitemid 46985178)
19. R. Yoshimura, A. Ikenouchi-Sugita, W. Umene-Nakano, H. Hori, N. Ueda, and J. Nakamura Nonadherence to paroxetine levels: a study based on monitoring plasma paroxetine Levels J Clin Psychopharmacol 30 2010 82 83
20. R.R. Bies, M.R. Gastonguay, K.C. Coley, P.D. Kroboth, and B.G. Pollock Evaluating the consistency of pharmacotherapy exposure by use of state-of-the-art techniques Am J Geriatr Psychiatry 10 2002 696 705 (Pubitemid 35315705)
21. E. Shemesh Non-adherence to medications following pediatric liver transplantation Pediatr Transplant 8 2004 600 605 (Pubitemid 40052362)
22. D. Brent, G. Emslie, and G. Clarke Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial JAMA 299 2008 901 913 (Pubitemid 351397065)
23. D.A. Brent, G. Emslie, and G. Clarke Predictors of spontaneous and systematically assessed suicidal adverse events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) Study Am J Psychiatry 166 2009 418 426
24. J.R. Asarnow, G. Emslie, and G. Clarke Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response J Am Acad Child Adolesc Psychiatry 48 2009 330 339
25. G. Emslie, T. Mayes, and G. Porta Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes Am J Psychiatry 167 2010 782 791
26. Vitiello B, Emslie G, Clarke G, et al. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up of the TORDIA sample. J Clin Psychiatry. [e-pub ahead of print: November 16, 2010].
27. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV 4th ed. 1994 American Psychiatric Association Washington, DC
28. E.O. Poznanski, L.N. Freeman, and H.B. Mokros Children's Depression Rating ScaleRevised Psychopharmacol Bull 21 1984 979 989
29. J. Kaufman, B. Birmaher, and D. Brent Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL): initial reliability and validity data J Am Acad Child Adolesc Psychiatry 36 1997 980 988 (Pubitemid 27272932)
30. A.T. Beck, R.A. Steer, and M.G. Garbin Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation Clin Psychol Rev 8 1988 77 100 (Pubitemid 18045797)
31. B. Birmaher, S. Khetarpal, and D. Brent The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics J Am Acad Child Adolesc Psychiatry 36 1997 545 553 (Pubitemid 27149193)
32. W.M. Reynolds, and J.J. Mazza Assessment of suicidal ideation in inner-city children and young adolescents: reliability and validity of the Suicidal Ideation QuestionnaireJR Sch Psychol Rev 28 1999 17 30
33. A.T. Beck, A. Weissman, D. Lester, and L. Trexler The measurement of pessimism: the Hopelessness Scale J Consult Clin Psychol 42 1974 861 865
34. L. Kirisci, A.C. Mezzich, and R.E. Tarter Norms and sensitivity of the adolescent version of the Drug Use Screening Inventory Addict Behav 20 1995 149 157
35. A.L. Robin, and S.L. Foster Negotiating parent-adolescent conflict: a behavioral-family systems approach 1989 Guilford Press New York
36. W. Guy ECDEU Assessment Manual for Psychopharmacology 2nd ed. 1976 US Government Printing Office Washington, DC Publication ADM 76-338
37. K. Posner, M. Oquendo, B. Stanley, M. Davies, and M. Gould Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants Am J Psychiatry 164 2007 1035 1043 (Pubitemid 47121392)
38. M. Byerly, R. Fisher, and K. Whatley A comparison of electronic monitoring versus clinician rating of antipsychotic adherence in outpatients with schizophrenia Psychiatry Res 133 2005 129 133 (Pubitemid 40312147)
39. J.P. Foglia, D. Sorisio, M.A. Kirshner, and B.G. Pollock Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detection J Chromatogr Biomed Appl 693 1997 147 151 (Pubitemid 27229626)
40. J. Foglia, B.G. Pollock, M. Kirshner, J. Rosen, R. Sweet, and B.H. Mulsant Plasma levels of citalopram enantioomers and metabolites in elderly patients Psychopharmacol Bull 33 1997 109 112 (Pubitemid 27184203)
41. J. Cohen A Coefficient of Agreement for Nominal Scales Educ Psychol Meas 20 1960 37 46
42. H.C. Kraemer, G.T. Wilson, C.G. Fairburn, and W.S. Agras Mediators and moderators of treatment effects in randomized clinical trials Arch Gen Psychiatry 59 2002 877 883
43. Y. Jin, B.G. Pollock, and E. Frank The effect of reporting methods for dosing times on the estimation of pharmacokinetic parameters of escitalopram J Clin Pharmacol 49 2009 176 184
44. B. Vrijens, and E. Goetghebeur Electronic monitoring of variation in drug intakes can reduce bias and improve precision in pharmacokinetic/ pharmacodynamic population studies Stat Med 23 2004 531 544 (Pubitemid 38208182)
45. M.M. Gomes, H.S. Maia Filho, and R.A. Noe Anti-epileptic drug intake adherence The value of the blood drug level measurement and the clinical approach Arq Neuropsiquiatr 56 1998 708 713 (Pubitemid 28550534)
46. M.R. Mavissakalian, and J.M. Perel Imipramine dose-response relationship in panic disorder with agoraphobia Preliminary findings Arch Gen Psychiatry 46 1989 127 131 (Pubitemid 19064098)
47. J.R. Matsuyama, B.J. Mason, and S.G. Jue Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts Ann Pharmacother 27 1993 851 855 (Pubitemid 23225667)
48. R. Grymonpre, M. Cheang, M. Fraser, C. Metge, and D.S. Sitar Validity of a prescription claims database to estimate medication adherence in older persons Med Care 44 2006 471 477 (Pubitemid 43755427)
49. C.L. Cook, W.E. Wade, B.C. Martin, and M. Perri III Concordance among three self-reported measures of medication adherence and pharmacy refill records J Am Pharm Assoc 45 2005 151 159 (Pubitemid 46037308)